![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 24, 2024 10:16:53 AM
If I knew anything about charts (and I don't) the AXIM charts don't tell me anything about the recent sales. Daily charts: Not much but we do have higher volume over the last month. However the volume is similar to higher volume in the month of March in past years. Nothing stands out yet. Weekly charts? Monthly charts? Nothing. Just a downhill ski-slope. Maybe word of mouth travels slower on OTC? The recent volume might suggest we have a few more eyeballs, but not many. The dollar amount behind the volume is still a very small amount.
AXIM is still spending way too much money compared to sales revenue. Verséa Ophthalmics as well. Even with all of the recent sales activity it might still be possible for failure if sales don't materialize fast enough. Both companies are spending way too much money. Both companies desperately need CLIA waiver approvals NOW. Or last month or last year.
As for me, I have more AXIM shares right now than I ever thought possible a couple years ago. However my new money is chasing other things right now. I'm hoping to catch lightning in a bottle somewhere else for the next 4 or 5 months so l can decide in August 2024 if I want a lot bigger position in AXIM. That's my plan. Things could change. But if we only get one new customer per week it will take a long time for AXIM to be cash-flow positive.
Not investment advice.
Do your own research.
Don't invest money needed for food or rent or happiness.
Recent AXIM News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM